Medindia

X

Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share

Tuesday, September 9, 2008 General News J E 4
Advertisement
CHICAGO, Sept. 8 Ventas, Inc. (NYSE: VTR)("Ventas" or the "Company") said today that its Board of Directors declared aregular quarterly dividend of $0.5125 per share, payable in cash on September30, 2008 to stockholders of record on September 19, 2008. The dividend is thethird quarterly installment of the Company's 2008 annual dividend.

Ventas, Inc. is a leading healthcare real estate investment trust. Itsdiverse portfolio of properties located in 43 states and two Canadianprovinces includes seniors housing communities, skilled nursing facilities,hospitals and medical office and other properties. More information aboutVentas can be found on its website at http://www.ventasreit.com.

This press release includes forward-looking statements within the meaningof Section 27A of the Securities Act of 1933, as amended, and Section 21E ofthe Securities Exchange Act of 1934, as amended. All statements regardingVentas, Inc.'s ("Ventas" or the "Company") and its subsidiaries' expectedfuture financial position, results of operations, cash flows, funds fromoperations, dividends and dividend plans, financing plans, business strategy,budgets, projected costs, capital expenditures, competitive positions,acquisitions, investment opportunities, merger integration, growthopportunities, expected lease income, continued qualification as a real estateinvestment trust ("REIT"), plans and objectives of management for futureoperations and statements that include words such as "anticipate," "if,""believe," "plan," "estimate," "expect," "intend," "may," "could," "should,""will" and other similar expressions are forward-looking statements. Suchforward-looking statements are inherently uncertain, and security holders mustrecognize that actual results may differ from the Company's expectations. TheCompany does not undertake a duty to update these forward-looking statements,which speak only as of the date on which they are made.

The Company's actual future results and trends may differ materiallydepending on a variety of factors discussed in the Company's filings with theSecurities and Exchange Commission. Factors that may affect the Company'splans or results include without limitation: (a) the ability and willingnessof the Company's operators, tenants, borrowers, managers and other thirdparties, as applicable, to meet and/or perform the obligations under theirvarious contractual arrangements with the Company; (b) the ability andwillingness of Kindred Healthcare, Inc. (together with its subsidiaries,"Kindred"), Brookdale Living Communities, Inc. (together with itssubsidiaries, "Brookdale") and Alterra Healthcare Corporation (together withits subsidiaries, "Alterra") to meet and/or perform their obligations toindemnify, defend and hold the Company harmless from and against variousclaims, litigation and liabilities under the Company's respective contractualarrangements with Kindred, Brookdale and Alterra; (c) the ability of theCompany's operators, tenants, borrowers and managers, as applicable, tomaintain the financial strength and liquidity necessary to satisfy theirrespective obligations and liabilities to third parties, including withoutlimitation obligations under their existing credit facilities; (d) theCompany's success in implementing its business strategy and the Company'sability to identify, underwrite, finance, consummate and integratediversifying acquisitions or investments, including those in different assettypes and outside the United States; (e) the nature and extent of futurecompetition; (f) the extent of future or pending healthcare reform andregulation, including cost containment measures and changes in reimbursementpolicies, procedures and rates; (g) increases in the Company's cost ofborrowing; (h) the ability of the Company's operators and managers, asapplicable, to deliver high quality services, to attract and retain qualifiedpersonnel and to attract reside
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Anadys Pharmaceuticals to Present at The Merriman ...
S
DiagnoCure announces third quarter 2008 results